Showing 1,510 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Hepatitis C transmission & prevention

Former Merck Unit Works on First Vaccine for Hepatitis C

Editor's pick
Bloomberg Business Week
22 March 2012
Cancer

Curing cancer: how genomics is speeding up research

Editor's pick
Financial Times
20 March 2012
Pharmaceutical industry

FDA Swayed By Politics & Industry: FDA Scientists

Editor's pick
Pharmalot
15 March 2012
The search for an HIV prevention vaccine

Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial

Editor's pick
Manual Items
14 March 2012
Access to healthcare

India's patent ruling on cancer may open door for cheaper HIV drugs

Editor's pick
Times of India
13 March 2012
New & experimental hepatitis C treatment

NICE recommends Victrelis in speedy review

Editor's pick
InPharm
9 March 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
New & experimental HIV treatments

Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study

News
8 March 2012
Pharmaceutical industry

New Greek law says industry must cover pharma overspend

Editor's pick
Pharma Times
8 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
Access to healthcare

Why global health activists are fired up about Novartis

Editor's pick
Science Speaks
27 February 2012
Access to healthcare

UNAIDS Executive Director calls for greater local production of HIV medicines in Ghana

Editor's pick
Myjoyonline.com
27 February 2012
Access to healthcare

Outcry from African NGOs over Cape Town intellectual property summit

Editor's pick
Key Correspondents
27 February 2012
Side effects

FDA Pain Patch Decision: Making a 'Sophie's Choice' with People's Lives

Editor's pick
HIVandHepatitis.com
20 February 2012
New & experimental hepatitis C treatment

Gilead Drops as Patients Relapse on Hepatitis C Drug

Editor's pick
Bloomberg Business Week
17 February 2012
New & experimental hepatitis C treatment

Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study

Editor's pick
Gilead press release
17 February 2012
Adherence

New 'smart pills' signal your iPhone

Editor's pick
Eurekalert Medicine & Health
15 February 2012
New & experimental hepatitis C treatment

Drugmakers Jockey for Piece of Future Hepatitis C Combo Pill

Editor's pick
Bloomberg Business Week
15 February 2012
PrEP

Gilead: FDA Fast Tracks Review Of HIV Drug Truvada

Editor's pick
Wall Street Journal
14 February 2012
New & experimental hepatitis C treatment

Gilead, Vertex and the Mystery of Missing Hep C Patients

Editor's pick
The Street
13 February 2012
Access to healthcare

SA announces HIV drugs partnership

Editor's pick
News24
10 February 2012
Access to healthcare

Sir Elton John: We must end the greed of these corporations

Editor's pick
The Independent
10 February 2012
Access to healthcare

EU drive to protect drug firms puts fight against Aids at risk

Editor's pick
The Independent
10 February 2012
Neurological & cognitive problems

NeurogesX Fails to Win U.S. FDA Panel Backing for Patch to Treat HIV Pain

Editor's pick
Bloomberg
9 February 2012